Karo Pharma AB buy Raymond James
Start price
16.01.25
/
50%
€5.44
Target price
16.01.26
€49.43
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 16.01.26. The prediction end date can be changed by Raymond_James at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Karo Pharma AB | - | - |
| iShares Core DAX® | 1.659% | 1.586% |
| iShares Nasdaq 100 | 0.381% | 1.900% |
| iShares Nikkei 225® | 2.102% | -1.377% |
| iShares S&P 500 | 0.221% | 1.258% |
Comments by Raymond_James for this prediction
In the thread Karo Pharma AB diskutieren
Karooooo Ltd. (NASDAQ: KARO) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $51.00 price target on the stock, up previously from $46.00.
Ratings data for KARO provided by MarketBeat